Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil versus nitroglycerin for controlled blood pressure during rhinoplasty
IRCT20210508051228N1Phase 2Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Sep 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in rhinoplasty comparing Remifentanil arm with Nitroglycerin arm (2 arms). Primary endpoint: blood pressure. Started Sep 2019; status: completed.
02
Drugs
remifentanilnitroglycerin
03
Conditions
rhinoplasty
Beyond the preview
Go deeper on IRCT20210508051228N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210508051228N1.